rs763986788
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000023.4(SGCA):c.488dupG(p.Leu164fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000629 in 1,431,788 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000063 ( 0 hom. )
Consequence
SGCA
NM_000023.4 frameshift
NM_000023.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.72
Genes affected
SGCA (HGNC:10805): (sarcoglycan alpha) This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-50168470-T-TG is Pathogenic according to our data. Variant chr17-50168470-T-TG is described in ClinVar as [Likely_pathogenic]. Clinvar id is 370116.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCA | NM_000023.4 | c.488dupG | p.Leu164fs | frameshift_variant | 5/10 | ENST00000262018.8 | NP_000014.1 | |
SGCA | NM_001135697.3 | c.488dupG | p.Leu164fs | frameshift_variant | 5/8 | NP_001129169.1 | ||
SGCA | NR_135553.2 | n.524dupG | non_coding_transcript_exon_variant | 5/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCA | ENST00000262018.8 | c.488dupG | p.Leu164fs | frameshift_variant | 5/10 | 1 | NM_000023.4 | ENSP00000262018.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000629 AC: 9AN: 1431788Hom.: 0 Cov.: 33 AF XY: 0.00000705 AC XY: 5AN XY: 709184
GnomAD4 exome
AF:
AC:
9
AN:
1431788
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
709184
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2D Pathogenic:6
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Feb 08, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Nov 27, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 24, 2023 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 03, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 03, 2023 | This premature translational stop signal has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 18996010). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Leu164Thrfs*27) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). ClinVar contains an entry for this variant (Variation ID: 370116). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 11, 2024 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2019 | The c.488dupG variant has been previously reported in an individual with limb-girdle weakness, calf hypertrophy, and elevated CK levels who harbored an additional SGCA variant (Klinge et al., 2008). The c.488dupG variant is not observed in large population cohorts (Lek et al., 2016). This variant causes a frameshift starting with codon Leucine 164, changes this amino acid to a Threonine residue, and creates a premature Stop codon at position 27 of the new reading frame, denoted p.Leu164ThrfsX27. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at